These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5369691)

  • 1. The need for additional alkylating agents.
    Connors TA
    Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative antitumor effects of peptichemio and other alkylating agents.
    Schmid FA; Banks SE; Stock CC
    Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
    [No Abstract]   [Full Text] [Related]  

  • 3. [The mechanism of tumor drug resistance].
    Kulik GI
    Vopr Onkol; 1969; 15(11):60-4. PubMed ID: 5368841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Structure and mode of action of alkylating agents used in the therapy of neoplastic diseases].
    Borresen HC
    Nord Med; 1969 Jan; 81(3):65-72. PubMed ID: 5767356
    [No Abstract]   [Full Text] [Related]  

  • 5. [The significance of connective tissue stimulation in antitumor chemotherapy].
    Diadosha GF; Bulkina ZP; Kononenko LI
    Vopr Onkol; 1968; 14(9):70-3. PubMed ID: 4971964
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
    Jugstand W; Gutsche W; Wiangke H
    Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
    Kulik GI
    Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
    [No Abstract]   [Full Text] [Related]  

  • 8. 3-N,N-bis(2-chloroethylamino)p-toluic acid, a new cytostatic drug active in cancer.
    Dobre V; Maltezeanu G
    Cancer Chemother Rep; 1970 Oct; 54(5):319-23. PubMed ID: 5514620
    [No Abstract]   [Full Text] [Related]  

  • 9. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.
    Geran RI; Congleton GF; Dudeck LE; Abbott BJ; Gargus JL
    Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy in isolation perfusion: use of mitotic inhibitors in pretreatment of V x 2 carcinoma undergoing isolation perfusion with alkylating agents.
    Mashima Y; Nagatsu M; Lambert A
    Cancer Chemother Rep; 1972 Apr; 56(2):175-81. PubMed ID: 5043225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative evaluation of the efficacy of antineoplastic agents].
    Karavainova MKh
    Farmakol Toksikol; 1971; 34(5):618-21. PubMed ID: 5004886
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane transport of alkylating agents.
    Goldenberg GJ; Begleiter A
    Pharmacol Ther; 1980; 8(2):237-74. PubMed ID: 6992155
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
    Clifford P; Singh S; Stjernswärd J; Klein G
    Cancer Res; 1967 Dec; 27(12):2578-615. PubMed ID: 6082297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
    Werner W; Jungstand W; Gutsche W
    Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
    [No Abstract]   [Full Text] [Related]  

  • 17. [A change in the concentrations of RNA, DNA and nicotinamide coenzymes in the tissues of rabbits undergoing treatment with alkylating agents for an experimental rheumatoid-arthritic process].
    Mishkinite GA; Iusene IaP
    Vopr Med Khim; 1974; 20(6):583-8. PubMed ID: 4156104
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio].
    Balitskiĭ KP; Veksler IG; Tsapenko VF
    Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antineoplastic activity of new preparations from the chlorethylamine group not affecting hemopoiesis].
    Vasil'eva LS; D'iachkovskaia RF; Shuppe NG; Parkhomenko II; Surkova NI
    Izv Akad Nauk SSSR Biol; 1970; 3():459-63. PubMed ID: 5491977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.